• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Colombia Pharmaceuticals and Healthcare Report Q2 2009 - Product Image

Colombia Pharmaceuticals and Healthcare Report Q2 2009

  • Published: April 2009
  • Region: Colombia
  • 71 Pages
  • Business Monitor International

FEATURED COMPANIES

  • AstraZeneca
  • Farmaindustria
  • GlaxoSmithKline
  • Hersil
  • Merck & Co
  • Novartis
  • MORE

Colombia Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Colombia's pharmaceuticals and healthcare industry.

In BMI’s updated Business Environment Ranking table for the Americas, Colombia’s score has remained the same, again ranking the country fifth out of the 10 major markets in the region. While the rising population numbers and a steady forecast market growth represent considerable draws for foreign companies, the persistent problems regarding its intellectual property (IP) environment – as well as the higher attractiveness of other larger and better regulated Latin American markets - will continue to hamper foreign direct investment (FDI) over the coming years.

Colombia’s drug market compound annual growth rate (CAGR) in local currency terms is forecast at a solid 11.56%, similar to the US dollar CAGR, which is expected at 12.04%. In theory, the future ratification of the penned Free Trade Agreement (FTA) by the US should provide a legal basis to continue to improve enforcement to meet its treaty obligations, although continued delays to the ratification of the deal are breeding uncertainty.

On READ MORE >

Executive Summary
Colombia Pharmaceutical And Healthcare Industry SWOT
Colombia Political SWOT Analysis
Colombia Economic SWOT Analysis
Colombia Business Environment SWOT Analysis

Pharmaceutical Business Environment Ratings
Table: Americas Pharmaceutical Business Environment Ratings for Q209
Limits To Potential Returns
Risks To Realisation Of Returns

Colombia – Market Summary

Regulatory Regime
Intellectual Property Environment
Counterfeit Pharmaceuticals
Proposed US Free Trade Agreement
Table: Colombia-US FTA Mechanisms Relevant To IP
Pricing And Reimbursement Issues
Other Regulatory Issues

Industry Developments
Epidemiology
Healthcare Sector
Healthcare Insurance
Healthcare Insurance Funding
Pharmaceutical Sector
Recent Pharmaceutical Company Developments
Clinical Trials
Medical Devices

Industry Forecast Scenario
Overall Market Forecast
Table: Colombia - Drug Market Indicators, Historical Data and Forecasts
Key Growth Factors – Industry
Table: Colombia - Health Expenditure Trends, Historical Data and Forecasts
Key Growth Factors – Macroeconomic
Table: Colombia - Economic Activity
Prescription Market Forecasts
Table: Colombia - Prescription Market Indicators, Historical Data and Forecasts (COPmn unless otherwise stated)
Patented Market Forecast
Table: Colombia - Patented Market Indicators, Historical Data and Forecasts
Generics Market Forecast
Table: Colombia - Generic Market Trends, Historical Data and Forecasts
OTC Market Forecasts
Table: Colombia - OTC Market Indicators, Historical Data and Forecasts (COPmn unless otherwise stated)
Pharmaceutical Trade Forecasts
Table: Colombia - Pharmaceuticals Trade Indicators, Historical Data and Forecasts (US$mn)
Medical Device Market Forecast
Table: Colombia – Medical Devices Market Indicators, Historical Data and Forecasts (US$mn unless otherwise stated)
Other Healthcare Data Forecasts
Table: Colombia – Other Healthcare Data Indicators, Historical Data and Forecasts
Key Risks To BMI’s Forecast Scenario

Competitive Landscape

Company Monitor
Leading Multinationals
GlaxoSmithKline (GSK)
Pfizer
Merck & Co
Sanofi-Aventis
Novartis
Indigenous Manufacturers
Tecnoquímicas
Lafrancol
Laboratorios Brussié

Country Snapshot: Colombia Demographic Data
Section 1: Population
Table: Demographic Indicators, 2005-2030
Table: Rural/Urban Breakdown, 2005-2030
Section 2: Education And Healthcare
Table: Education, 2002-2005
Table: Vital Statistics, 2005-2030
Table: Employment Indicators, 2001-2006
Table: Consumer Expenditure, 2000-2012 (US$)
Table: Average Annual Wages, 2000-2012

BMI Forecast Modelling
How We Generate Our Pharmaceutical Industry Forecasts
Pharmaceutical Business Environment Ratings Methodology
Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Weighting
Table: Weighting Of Components
Sources

- Sanofi-Aventis
- Merck & Co
- GlaxoSmithKline
- Novartis
- Pfizer
- AstraZeneca
- Farmaindustria
- Unimed
- Hersil

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos